These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9088268)

  • 1. Familial prostate cancer studies in Utah.
    Neuhausen SL; Skolnick MH; Cannon-Albright L
    Br J Urol; 1997 Mar; 79 Suppl 1():15-20. PubMed ID: 9088268
    [No Abstract]   [Full Text] [Related]  

  • 2. Replication of the 10q11 and Xp11 prostate cancer risk variants: results from a Utah pedigree-based study.
    Camp NJ; Farnham JM; Wong J; Christensen GB; Thomas A; Cannon-Albright LA
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1290-4. PubMed ID: 19336566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of a prostate cancer predisposition gene to an 880-kb region on chromosome 22q12.3 in Utah high-risk pedigrees.
    Camp NJ; Farnham JM; Cannon-Albright LA
    Cancer Res; 2006 Oct; 66(20):10205-12. PubMed ID: 17047086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of specific Y chromosomes associated with increased prostate cancer risk.
    Cannon-Albright LA; Farnham JM; Bailey M; Albright FS; Teerlink CC; Agarwal N; Stephenson RA; Thomas A
    Prostate; 2014 Jun; 74(9):991-8. PubMed ID: 24796687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic search for prostate cancer predisposition loci in Utah pedigrees.
    Camp NJ; Farnham JM; Cannon Albright LA
    Prostate; 2005 Dec; 65(4):365-74. PubMed ID: 16037989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confirmation of the HPCX prostate cancer predisposition locus in large Utah prostate cancer pedigrees.
    Farnham JM; Camp NJ; Swensen J; Tavtigian SV; Albright LA
    Hum Genet; 2005 Feb; 116(3):179-85. PubMed ID: 15592687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search.
    Smith JR; Freije D; Carpten JD; Grönberg H; Xu J; Isaacs SD; Brownstein MJ; Bova GS; Guo H; Bujnovszky P; Nusskern DR; Damber JE; Bergh A; Emanuelsson M; Kallioniemi OP; Walker-Daniels J; Bailey-Wilson JE; Beaty TH; Meyers DA; Walsh PC; Collins FS; Trent JM; Isaacs WB
    Science; 1996 Nov; 274(5291):1371-4. PubMed ID: 8910276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide linkage analysis for aggressive prostate cancer in Utah high-risk pedigrees.
    Christensen GB; Camp NJ; Farnham JM; Cannon-Albright LA
    Prostate; 2007 May; 67(6):605-13. PubMed ID: 17299800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homing in on prostate cancer gene.
    Pennisi E
    Science; 1996 Nov; 274(5291):1301. PubMed ID: 8966598
    [No Abstract]   [Full Text] [Related]  

  • 10. Familial prostate cancer: the evidence and the Cancer Research Campaign/British Prostate Group (CRC/BPG) UK Familial Prostate Cancer Study.
    Eeles RA; Dearnaley DP; Ardern-Jones A; Shearer RJ; Easton DF; Ford D; Edwards S; Dowe A
    Br J Urol; 1997 Mar; 79 Suppl 1():8-14. PubMed ID: 9088267
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate cancer screening, changing age-specific incidence trends and implications on familial risk.
    Hemminki K; Rawal R; Bermejo JL
    Int J Cancer; 2005 Jan; 113(2):312-5. PubMed ID: 15386407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial prostate cancer.
    Stanford JL; Ostrander EA
    Epidemiol Rev; 2001; 23(1):19-23. PubMed ID: 11588848
    [No Abstract]   [Full Text] [Related]  

  • 13. Statistical recombinant mapping in extended high-risk Utah pedigrees narrows the 8q24 prostate cancer locus to 2.0 Mb.
    Camp NJ; Farnham JM; Allen-Brady K; Cannon-Albright LA
    Prostate; 2007 Sep; 67(13):1456-64. PubMed ID: 17654497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gene for hereditary prostatic cancer has been located. New possibilities for early identification of men at risk].
    Grönberg H; Bergh A; Damber JE
    Lakartidningen; 1998 Apr; 95(14):1522-5. PubMed ID: 9564139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiology of familial prostatic cancer: 4-year assessment of French studies].
    Valeri A; Drelon E; Azzouzi R; Delannoy A; Teillac P; Fournier G; Mangin P; Berthon P; Cussenot O
    Prog Urol; 1999 Sep; 9(4):672-9. PubMed ID: 10555220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic, epidemiologic and clinical study of familial prostate cancer].
    Valéri A
    Bull Acad Natl Med; 2002; 186(4):779-88; discussion 788-91. PubMed ID: 12412374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing a familial basis for papillary thyroid carcinoma using the Utah Population Database.
    Oakley GM; Curtin K; Pimentel R; Buchmann L; Hunt J
    JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1171-4. PubMed ID: 24092278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic epidemiology of cancer in Utah genealogies: a prelude to the molecular genetics of common cancers.
    Bishop DT; Skolnick MH
    J Cell Physiol Suppl; 1984; 3():63-77. PubMed ID: 6589230
    [No Abstract]   [Full Text] [Related]  

  • 19. Toward a better understanding of the comparatively high prostate cancer incidence rates in Utah.
    Merrill RM; Hilton SC; Wiggins CL; Sturgeon JD
    BMC Cancer; 2003 Apr; 3():14. PubMed ID: 12720571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted screening for prostate cancer in high risk families: early onset is a significant risk factor for disease in first degree relatives.
    Valeri A; Cormier L; Moineau MP; Cancel-Tassin G; Azzouzi R; Doucet L; Baschet F; Cussenot I; L'Her J; Berthon P; Mangin P; Cussenot O; Morin JF; Fournier G
    J Urol; 2002 Aug; 168(2):483-7. PubMed ID: 12131293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.